Phase II and pharmacodynamic study of autophagy inhibition using hydroxychloroquine in patients with metastatic pancreatic adenocarcinoma. - Wikidata - wikimedia - TriplyDB

Phase II and pharmacodynamic study of autophagy inhibition using hydroxychloroquine in patients with metastatic pancreatic adenocarcinoma.

Phase II and pharmacodynamic study of autophagy inhibition using hydroxychloroquine in patients with metastatic pancreatic adenocarcinoma.

http://www.wikidata.org/entity/Q33699665

about

Pancreatic cancer from bench to bedside: molecular pathways and treatment options KRAS Mutant Pancreatic Cancer: No Lone Path to an Effective Treatment Leaving the lysosome behind: novel developments in autophagy inhibition Pancreatic Cancer Metabolism: Breaking It Down to Build It Back Up The different roles of selective autophagic protein degradation in mammalian cells Amino acid management in cancer Chloroquine and hydroxychloroquine for cancer therapy Autophagy in malignant transformation and cancer progression Emerging strategies to effectively target autophagy in cancer Macropinocytosis Exploitation by Cancers and Cancer Therapeutics Autophagy- An emerging target for melanoma therapy Therapeutic Targeting of Autophagy Nanomedicine strategies to overcome the pathophysiological barriers of pancreatic cancer.Reactive oxygen species and autophagy modulation in non-marine drugs and marine drugs.Autophagy and its effects: making sense of double-edged swords.The receptor for advanced glycation end products (RAGE) enhances autophagy and neutrophil extracellular traps in pancreatic cancer.Transforming Growth Factor TGFβ Increases Levels of Microtubule-Associated Protein MAP1S and Autophagy Flux in Pancreatic Ductal Adenocarcinomas Safety and Biologic Response of Pre-operative Autophagy Inhibition in Combination with Gemcitabine in Patients with Pancreatic Adenocarcinoma.Therapeutic Approaches to RAS Mutation.Recent insights into the function of autophagy in cancer.Antitumor adaptive immunity remains intact following inhibition of autophagy and antimalarial treatment.Autophagy-dependent danger signaling and adaptive immunity to poorly immunogenic tumors.Cellular and metabolic functions for autophagy in cancer cells.Metabolic Dependencies in RAS-Driven Cancers.Targeting cancer cell metabolism in pancreatic adenocarcinoma.Lysosomal Biology in Cancer.Clinical relevance of autophagic therapy in cancer: Investigating the current trends, challenges, and future prospects.Targeting metabolic reprogramming in KRAS-driven cancers.Autophagy in 5-Fluorouracil Therapy in Gastrointestinal Cancer: Trends and Challenges.Activating autophagy to potentiate immunogenic chemotherapy and radiation therapy.Oxidative pentose phosphate pathway inhibition is a key determinant of antimalarial induced cancer cell death.Molecular Pathways Controlling Autophagy in Pancreatic Cancer.Research progress of hydroxychloroquine and autophagy inhibitors on cancer.Hydroxychloroquine retinopathy.Autophagy and Tumor Metabolism.Targeting Autophagy in Cancer: Update on Clinical Trials and Novel Inhibitors.Autophagy Inhibition Dysregulates TBK1 Signaling and Promotes Pancreatic Inflammation.Selective cytotoxicity of vanadium complexes on human pancreatic ductal adenocarcinoma cell line by inducing necroptosis, apoptosis and mitotic catastrophe process.A unified approach to targeting the lysosome's degradative and growth signaling roles.Targeting autophagy in cancer.

P2860

Q26747524-A7ABB956-A2D5-4D43-9FEE-84F4D3537137 Q26751520-062F2EC9-0078-4244-8CE3-A25FE68960C7 Q26774549-1131F875-D9D3-4470-B651-9493F196C297 Q26780372-C71DE066-D354-42F2-B253-F98E96AFB54F Q26785503-29201944-B500-4BC0-8E7F-22DCE08C1B10 Q26798087-46338B3A-892E-405C-B1A5-EAD3AA140D2B Q26827797-A6B8A207-DCE8-455E-89ED-20AF754DA12A Q27000191-04FDE656-C3A5-454D-BB79-50CE51C8781D Q27009194-B87AAD77-8AC8-4F9E-8CB9-5C682C50313D Q28069487-C925E639-3B98-484C-818E-02BF40C2A723 Q28071400-C2A7ACB3-C789-41C1-9379-71CA5B544AC8 Q28078117-B0EB686C-1694-4B55-BE58-FB7CF99A7DD3 Q34537580-57FA952D-8419-4D2B-AE68-D6308A3B3EB3 Q34577847-4D683E40-2937-457E-B071-1D76930274B5 Q35330324-D460921B-C25F-4FBE-9EE4-A32335327E5A Q35752134-1731BC3B-84FC-43AF-AD55-6907BC6ACA36 Q35841939-783BEEA4-6A97-42A3-9CF9-AF6CE50E35B7 Q36329393-DC524ECB-C952-4D6D-8215-11F66BB813FE Q37122874-72880566-CA48-4994-B4CE-E9B7C4D284AC Q37343004-B79085D2-6590-44F8-883C-5368FF99AE3C Q37452252-6FE84BC9-53C7-4C0B-9C60-D3F796276414 Q37701461-E43CB8BB-2428-482D-BD84-61263DB3CBE7 Q38256306-8C52CB87-265C-4B75-A2FD-D4DD6AF5EC90 Q38423050-E4250DB2-6D16-4C7F-BEF8-1E50974A28AF Q38545275-9E7ED3DB-26EA-4676-A634-B7AA796FA4AD Q38689342-A38AEE47-7F15-47BF-9087-74BDC86DB8C6 Q38689955-946FC514-914B-496D-A8E1-D564784A7C60 Q38710288-335E3FF2-277F-436F-A483-13EDE986389D Q38734363-8C5C242E-7E48-4B95-B621-75F6756D8036 Q38795278-A687C675-ECB3-4E3E-A72A-FCC55C7132C3 Q38830428-DD64596D-5515-4DBA-967E-008F16310113 Q38895232-024F7F3B-C5E8-49EC-BD13-F1DCAB257AD0 Q39021076-EE7E98C8-ED3A-4A58-8C1D-5E962A4B2DB3 Q39172826-E2D8A60F-851B-44AC-B6F8-A26CA637BBF3 Q39280823-3CC449F4-C94A-401D-AEB2-A4D580A9D180 Q39378223-DB0A1013-987D-43E2-B62B-DAB5A11C1691 Q40805952-A828C47B-68FA-46C8-B48B-5A70D3D0BB51 Q41694174-9214C069-C7F7-46E1-9218-61E82D31BAA1 Q41911972-C0349A97-9B8A-4564-8A6C-6A7E88DE6C9C Q41912265-A95D0FE3-CC4A-495D-B807-C7B461611A4E

P2860

Phase II and pharmacodynamic study of autophagy inhibition using hydroxychloroquine in patients with metastatic pancreatic adenocarcinoma.

http://www.wikidata.org/entity/Q33699665

description

2014 nî lūn-bûn

@nan

2014 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Phase II and pharmacodynamic s ...... tic pancreatic adenocarcinoma.

@ast

Phase II and pharmacodynamic s ...... tic pancreatic adenocarcinoma.

@en

type

label

Phase II and pharmacodynamic s ...... tic pancreatic adenocarcinoma.

@ast

Phase II and pharmacodynamic s ...... tic pancreatic adenocarcinoma.

@en

prefLabel

Phase II and pharmacodynamic s ...... tic pancreatic adenocarcinoma.

@ast

Phase II and pharmacodynamic s ...... tic pancreatic adenocarcinoma.

@en

P1433

Q33699665-30C528E5-CB96-4655-8448-EEC8C6B30B08

P1476

Q33699665-FDBD5E9E-C4CB-43DF-824A-60FD64763023

P2093

Q33699665-1EF4D343-2EC2-4115-9C8F-86EB8947D579

Q33699665-282B9EB6-D842-4947-9711-00275CD7AFE4

Q33699665-5C97DDB9-5E13-4D61-8043-836717E72C1B

Q33699665-6155FA03-AEDC-42AA-8D3C-CBB076638136

Q33699665-6DAADA63-F8BD-40E5-B07C-8BA7DDDF573C

Q33699665-6DE31B9B-00F0-401C-945A-5DC498FA2017

Q33699665-7C7AF9F3-8EC1-4836-863A-E1510BC4A2FB

Q33699665-9EED8A8C-D0C7-4BB6-BED5-9ABB70C0CFEA

Q33699665-B6209628-AA9A-4250-80AC-B99C0C5EDE3C

Q33699665-B63EFC42-49E8-4360-AA2E-330EC37B89ED

P304

Q33699665-C7367A78-9E9C-4F9F-A4F6-EDD242C89274

P31

Q33699665-D418F9BF-28AF-46FE-B87D-C51ECDB3158C

P356

Q33699665-6893084D-4DD0-4141-9F26-E13787E6A799

P433

Q33699665-D1E2F4FA-305B-4431-876F-0902236040CC

P478

Q33699665-C0DF559A-731B-4F68-AB17-AB0D3F86FDB6

P50

Q33699665-34A299B2-84BE-4573-BA9B-84780C639A61

Q33699665-F49CD3C5-2E8F-4C81-A437-17EB5423381C

P577

Q33699665-0576E63A-569E-4183-9C53-CD7A8C3D580A

P5875

Q33699665-628326BB-B072-4C1A-8F43-918C4968A1E1

P698

Q33699665-88AF603B-C317-49E7-8389-0DF6474D7C6D

P921

Q33699665-4475394F-244D-46FC-915D-D973764BA836

Q33699665-A5AC55FE-88CA-4078-87D1-8C51052B651D

Q33699665-D771265C-DD6D-43B6-BAE1-A7EFD30EF9EC

P932

Q33699665-3624762B-F2AB-4A9E-872F-B77D7DDF249B

P356

THEONCOLOGIST.2014-0086

P1433

P1476

Phase II and pharmacodynamic s ...... tic pancreatic adenocarcinoma.

@en

P2093

Alec C Kimmelman

http://www.w3.org/2001/XMLSchema#string

Allison L Sikora

http://www.w3.org/2001/XMLSchema#string

Beverly A Spicer

http://www.w3.org/2001/XMLSchema#string

Brian M Wolpin

http://www.w3.org/2001/XMLSchema#string

Deborah Schrag

http://www.w3.org/2001/XMLSchema#string

Douglas A Rubinson

http://www.w3.org/2001/XMLSchema#string

Harvey Mamon

http://www.w3.org/2001/XMLSchema#string

James M Cleary

http://www.w3.org/2001/XMLSchema#string

Jennifer A Chan

http://www.w3.org/2001/XMLSchema#string

Kimmie Ng

http://www.w3.org/2001/XMLSchema#string

P304

637-638

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1634/THEONCOLOGIST.2014-0086

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P50

Charles S. Fuchs

Jeffrey A Meyerhardt

P577

2014-05-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262267049

http://www.w3.org/2001/XMLSchema#string

P698

24821822

http://www.w3.org/2001/XMLSchema#string

P921

hydroxychloroquine

P932

4041680

http://www.w3.org/2001/XMLSchema#string